Samuel Achilefu

22PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCondensed matter imagingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathways.

Christopher Egbulefu, Kvar Black, Xinming Su

|Jan 09, 2026
Homing and Detection of Unknown Primary Head-Neck Cancer by Acid-Sensing Nanoparticles.

Jinming Gao, Qiang Feng, Jun Chen

|Apr 01, 2024
Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapse.

Christopher Egbulefu, Kvar Black, Xinming Su

|Jun 05, 2023
Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance.

Xiaoqing Cheng, Yirui Sun, Maureen Highkin

|Jan 27, 2023
Gold nanoparticle-enhanced X-ray microtomography of the rodent reveals region-specific cerebrospinal fluid circulation in the brain.

Shelei Pan, Peter H Yang, Dakota DeFreitas

|Dec 08, 2022
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice.

Sena Kim, Sora Lim, Boram Kim

Pageof 4

Frequent Collaborators

3 joint publications

Rui Tang

2 joint publications

Evan Moss

2 joint publications

Christopher Egbulefu

2 joint publications

Pratim Biswas